Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy

PHASE2RecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
LeprosyLeprosy, MultibacillaryNeglected Tropical Diseases
Interventions
DRUG

Metformin

Metformin 1000mg XR OD + standard-of-care MDT

DRUG

Placebo

Placebo + standard-of-care MDT

Trial Locations (6)

15121

RECRUITING

Sitanala Leprosy Hospital, Tangerang

92161

RECRUITING

Palangga Health Center, Makassar

92211

RECRUITING

Bajeng Health Center, Makassar

Unknown

RECRUITING

Abe Pantai Community Health Center, Jayapura

WITHDRAWN

Hamadi Community Health Center, Jayapura

RECRUITING

Jayapura Utara Community Health Center, Jayapura

All Listed Sponsors
collaborator

University of Gadjah Mada, Faculty of Medicine

UNKNOWN

collaborator

University of Diponegoro

UNKNOWN

collaborator

Papua Agency of Health Research and Development (NIHRD)

UNKNOWN

collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Oxford University Clinical Research Unit

UNKNOWN

lead

Oxford University Clinical Research Unit Indonesia

OTHER